Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome
Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome
Compared with medical therapy, percutaneous coronary intervention has been shown to reduce the rates of death and recurrent ischemia in patients presenting with acute coronary syndromes (ACS). In the current interventional era, both drug-eluting stents (DES) and bare-metal stents (BMS) have been widely used, despite the fact that the use of DES in the context of ACS was initially an “off-label” indication and that ACS has been associated with stent thrombosis (ST). In contrast to the wealth of data available for the use of DES in patients with ST-elevation myocardial infarction, data regarding the performance of DES in non–ST-elevation ACS is restricted to a handful of registries with conflicting data. The aim of this review was to summarize the safety and efficacy of DES in the entire spectrum of ACS.
385-390
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Delhaye, Cedric
d6bfe64b-8b52-4e6c-b505-497ef64195ff
Waksman, Ron
23d6bf65-0556-4930-8fad-224a559b34e0
November 2011
Mahmoudi, Michael
f6a55246-399e-4f81-944e-a4b169786e8a
Delhaye, Cedric
d6bfe64b-8b52-4e6c-b505-497ef64195ff
Waksman, Ron
23d6bf65-0556-4930-8fad-224a559b34e0
Mahmoudi, Michael, Delhaye, Cedric and Waksman, Ron
(2011)
Safety and efficacy of drug-eluting stents and bare metal stents in acute coronary syndrome.
Cardiovascular Revascularization Medicine, 12 (6), .
(doi:10.1016/j.carrev.2011.01.001).
Abstract
Compared with medical therapy, percutaneous coronary intervention has been shown to reduce the rates of death and recurrent ischemia in patients presenting with acute coronary syndromes (ACS). In the current interventional era, both drug-eluting stents (DES) and bare-metal stents (BMS) have been widely used, despite the fact that the use of DES in the context of ACS was initially an “off-label” indication and that ACS has been associated with stent thrombosis (ST). In contrast to the wealth of data available for the use of DES in patients with ST-elevation myocardial infarction, data regarding the performance of DES in non–ST-elevation ACS is restricted to a handful of registries with conflicting data. The aim of this review was to summarize the safety and efficacy of DES in the entire spectrum of ACS.
This record has no associated files available for download.
More information
Accepted/In Press date: 7 January 2011
e-pub ahead of print date: 16 February 2011
Published date: November 2011
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 396126
URI: http://eprints.soton.ac.uk/id/eprint/396126
ISSN: 1553-8389
PURE UUID: 3d569749-272e-4170-94b4-dd6ba757c6d8
Catalogue record
Date deposited: 14 Jul 2016 15:53
Last modified: 15 Mar 2024 03:54
Export record
Altmetrics
Contributors
Author:
Cedric Delhaye
Author:
Ron Waksman
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics